ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

Funding Opportunities.

June 28, 2002

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September

April 5, 1985